A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine

Citation
Jp. Valat et al., A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine, INFLAMM RES, 50, 2001, pp. S30-S34
Citations number
18
Categorie Soggetti
Immunology
Journal title
INFLAMMATION RESEARCH
ISSN journal
10233830 → ACNP
Volume
50
Year of publication
2001
Supplement
1
Pages
S30 - S34
Database
ISI
SICI code
1023-3830(200103)50:<S30:ACOTEA>2.0.ZU;2-T
Abstract
Objective: The aim of this study was to evaluate the efficacy and tolerabil ity of meloxicam compared with diclofenac in patients with osteoarthritis o f the lumbar spine. Subjects: 229 patients with radiologically confirmed osteoarthritis of the lumbar spine. Treatment and Methods: Once-daily meloxicam 7.5 mg tablet or diclofenac 100 mg slow release tablet. Efficacy and tolerability parameters were assessed at baseline and after 3, 7 and 14 days of treatment. Results: The two drugs had equal short-term efficacy, with pain on motion o f lumbar spine significantly (p < 0.05) decreased at Day 3. Secondary effic acy variables were also significantly improved at Days 3, 7 and 14. There w ere no statistically significant differences between the two drugs, althoug h the global tolerability of meloxicam was significantly better than for di clofenac, as assessed by the investigators (p = 0.0072) and the patients (p = 0.049). Conclusions: Meloxicam and diclofenac were equivalent in relieving the acut e pain associated with osteoarthritis of the lumbar spine. However, meloxic am was much better tolerated.